{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:22Z","timestamp":1792787902863,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3395-z","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T06:34:09Z","timestamp":1538548449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-0111","authenticated-orcid":false,"given":"Desmond","family":"Curran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruprecht","family":"Schmidt-Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Schutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastassia","family":"Anastassopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"3395_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMcp1302674","volume":"369","author":"JI Cohen","year":"2013","unstructured":"Cohen JI. Herpes zoster. N Engl J Med. 2013;369:255\u201363.","journal-title":"N Engl J Med"},{"key":"3395_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1128\/CMR.00052-13","volume":"26","author":"AA Gershon","year":"2013","unstructured":"Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiology Rev. 2013;26:728\u201343.","journal-title":"Clin Microbiology Rev"},{"key":"3395_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1741-7015-8-37","volume":"8","author":"RW Johnson","year":"2010","unstructured":"Johnson RW, Bouhassira D, Kassianos G, Leplege A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8:37.","journal-title":"BMC Med"},{"key":"3395_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcgg.2013.03.001","volume":"4","author":"G Mick","year":"2013","unstructured":"Mick G, Hans G. Postherpetic neuralgia in Europe: the scale of the problem and outlook for the future. J Clin Geron Geriat. 2013;4:102\u20138.","journal-title":"J Clin Geron Geriat"},{"issue":"Suppl. 8","key":"3395_CR5","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1212\/WNL.45.12_Suppl_8.S52","volume":"45","author":"E Lydick","year":"1995","unstructured":"Lydick E, Epstein RS, Himmelberger D, White CJ. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology. 1995;45(Suppl. 8):S52\u20133.","journal-title":"Neurology"},{"key":"3395_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.pain.2011.10.026","volume":"153","author":"D Bouhassira","year":"2012","unstructured":"Bouhassira D, Chassany O, Gaillat J, Hanslik T, Launay O, Mann C, et al. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain. 2012;153:342\u20139.","journal-title":"Pain"},{"key":"3395_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2334-11-173","volume":"11","author":"B Ultsch","year":"2011","unstructured":"Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wickmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173.","journal-title":"BMC Infect Dis"},{"key":"3395_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10389-010-0323-0","volume":"18","author":"T Weinke","year":"2010","unstructured":"Weinke T, Edte A, Schmitt S, Lukas K. Impact of herpes zoster and post-herpetic neuralgia on patients\u2019 quality of life: a patient-reported outcomes survey. J Public Health. 2010;18:367\u201374.","journal-title":"J Public Health."},{"key":"3395_CR9","doi-asserted-by":"publisher","unstructured":"Weinke T, Glogger A, Bertrand I, Lukas K. The societal impact of herpes zoster and postherpetic neuralgia on patients, life partners, and children of patients in Germany. Scientific World J. 2014; \n                    dx.doi.org\n                    \n                  . \n                    https:\/\/doi.org\/10.1155\/2014\/479698\n                    \n                  .","DOI":"10.1155\/2014\/479698"},{"key":"3395_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/1472-6963-13-359","volume":"13","author":"B Ultsch","year":"2013","unstructured":"Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res. 2013;13:359.","journal-title":"BMC Health Serv Res"},{"key":"3395_CR11","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010;182:1731\u20136.","journal-title":"CMAJ"},{"issue":"5","key":"3395_CR12","first-page":"475","volume":"76","author":"R Schmidt-Ott","year":"2018","unstructured":"Schmidt-Ott R, Schutter U, Simon J, Nautrup BP, von Krempelhuber A, Gopala K, Anastassopoulou A, Guignard A, Curran D, Matthews S, Espi\u00e9 E. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged \u226550 years: a prospective study. J Inf Secur. 2018;76(5):475\u201382.","journal-title":"J Inf Secur"},{"key":"3395_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","volume":"5","author":"PM Coplan","year":"2004","unstructured":"Coplan PM, Schmader K, Nikas A, Chan IS, Choo P, Levin MJ, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;5:344\u201356.","journal-title":"J Pain"},{"key":"3395_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33:337\u201343.","journal-title":"Ann Med"},{"key":"3395_CR15","unstructured":"EuroQol, 2016. Website of the EuroQol group. \n                    www.euroqol.org\n                    \n                  . Accessed 16 Nov 2016."},{"key":"3395_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/sim.4780090809","volume":"9","author":"AH Zwinderman","year":"1990","unstructured":"Zwinderman AH. The measurement of change of quality of life in clinical trials. Stat Med. 1990;9:931\u201342.","journal-title":"Stat Med"},{"key":"3395_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF00635621","volume":"1","author":"AH Zwinderman","year":"1992","unstructured":"Zwinderman AH. Statistical analysis of longitudinal quality of life data with missing measurements. Qual Life Res. 1992;1:219\u201324.","journal-title":"Qual Life Res"},{"key":"3395_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1191\/0962280202sm270ra","volume":"11","author":"D Curran","year":"2002","unstructured":"Curran D, Molenberghs G, Aaronson NK, Fossa SD, Sylvester RJ. Analysing longitudinal continuous quality of life data with dropout. Stat Methods Med Res. 2002;11:5\u201323.","journal-title":"Stat Methods Med Res"},{"key":"3395_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1081\/BIP-120028510","volume":"14","author":"D Curran","year":"2004","unstructured":"Curran D, Molenberghs G, Thijs H, Verbeke G. Sensitivity analysis for pattern mixture models. J Biopharm Stat. 2004;14:125\u201343.","journal-title":"J Biopharm Stat"},{"key":"3395_CR20","volume-title":"Linear mixed models for longitudinal data","author":"G Verbeke","year":"2002","unstructured":"Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer Verlag; 2002."},{"key":"3395_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass. 1958;53:457\u201381.","journal-title":"J Am Stat Ass"},{"issue":"7","key":"3395_CR22","doi-asserted-by":"publisher","first-page":"A668","DOI":"10.1016\/j.jval.2013.08.1925","volume":"16","author":"C. Vujacich","year":"2013","unstructured":"Vujacich C, de Wouters L, Margari A, Gordovil M, Kawai K, Lemos E et al. Assessment of burden of illness due to herpes zoster in Argentina: a prospective observational study. Value Health 2013;16:A668 (Abstract only).","journal-title":"Value in Health"},{"key":"3395_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijid.2013.11.018","volume":"20","author":"H Song","year":"2014","unstructured":"Song H, Lee J, Lee M, Choi WS, Choi JH, Lee MS, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014;20:23\u201330.","journal-title":"Int J Infect Dis"},{"key":"3395_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2334-14-402","volume":"14","author":"A Gater","year":"2014","unstructured":"Gater A, Abetz-Webb L, Carroll S, Mannan A, Serpell M, Johnson R. Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study. BMC Infect Dis. 2014;14:40.","journal-title":"BMC Infect Dis"},{"key":"3395_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/ijd.12484","volume":"54","author":"TF Tsai","year":"2015","unstructured":"Tsai TF, Yao CA, Yu HS, Lan CC, Chao SC, Yang JH, et al. Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study. Int J Dermatol. 2015;54:529\u201336.","journal-title":"Int J Dermatol"},{"key":"3395_CR26","first-page":"185","volume":"5","author":"NY Gu","year":"2012","unstructured":"Gu NY, Bell C, Botteman MF, Ji X, Carter JA, van Hout B. Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores. Patient. 2012;5:185\u201397.","journal-title":"Patient"},{"key":"3395_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/ageing\/afj048","volume":"35","author":"R van Seventer","year":"2006","unstructured":"van Seventer R, Sadosky A, Lucero M, Dukes E. A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing. 2006;35:132\u20137.","journal-title":"Age Ageing"},{"key":"3395_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10389-011-0481-8","volume":"20","author":"K Lukas","year":"2012","unstructured":"Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. J Public Health. 2012;20:441\u201351.","journal-title":"J Public Health"},{"key":"3395_CR29","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","volume":"14","author":"SJ Walters","year":"2005","unstructured":"Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523\u201332.","journal-title":"Qual Life Res"},{"key":"3395_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0895-4356(98)00036-5","volume":"51","author":"MV Bala","year":"1998","unstructured":"Bala MV, Wood LL, Zarkin GA, Norton EC, Gafni A, O\u2019Brien B. Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years. J Clin Epidemiol. 1998;51:667\u201376.","journal-title":"J Clin Epidemiol"},{"key":"3395_CR31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jpain.2005.01.359","volume":"6","author":"G Oster","year":"2005","unstructured":"Oster G, Harding G, Dukes E, Edlesberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain. 2005;6:356\u201363.","journal-title":"J Pain"},{"key":"3395_CR32","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","volume":"25","author":"JM Pellissier","year":"2007","unstructured":"Pellissier JM, Brisson M, Levin MJ. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine. 2007;25:8326\u201337.","journal-title":"Vaccine"},{"key":"3395_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1477-7525-12-92","volume":"12","author":"M Serpell","year":"2014","unstructured":"Serpell M, Gater A, Carroll S, Abetz-Webb L, Mannan A, Johnson R. Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the zoster quality of life (ZQOL) study. Health Qual Life Outcomes. 2014;12:92.","journal-title":"Health Qual Life Outcomes"},{"key":"3395_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1477-7525-8-47","volume":"8","author":"HH K\u00f6nig","year":"2010","unstructured":"K\u00f6nig HH, Heider D, Lehnert T, Riedel-Heller S, Angermeyer MC, Matschinger H, et al. Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12. Health Qual Life Outcomes. 2010;8:143.","journal-title":"Health Qual Life Outcomes"},{"key":"3395_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1037\/0021-843X.101.1.200","volume":"101","author":"RH Dworkin","year":"1992","unstructured":"Dworkin RH, Hartstein G, Rosner HL, Walther RR, Sweeney EW, Brand L. A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol. 1992;101:200\u20135.","journal-title":"J Abnorm Psychol"},{"issue":"Suppl 2","key":"3395_CR36","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1086\/522152","volume":"197","author":"K Schmader","year":"2008","unstructured":"Schmader K, Gnann JW, Jr WCP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008;197(Suppl 2):S207\u201315.","journal-title":"J Infect Dis"},{"key":"3395_CR37","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1086\/421942","volume":"39","author":"J Katz","year":"2004","unstructured":"Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004;39:342\u20138.","journal-title":"Clin Infect Dis"},{"key":"3395_CR38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/AJP.0b013e318065b6c9","volume":"23","author":"KE Schmader","year":"2007","unstructured":"Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain. 2007;23:490\u20136.","journal-title":"Clin J Pain"},{"key":"3395_CR39","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.vaccine.2014.01.058","volume":"32","author":"K Kawai","year":"2014","unstructured":"Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Vaccine. 2014;32:1645\u201353.","journal-title":"Vaccine"},{"key":"3395_CR40","doi-asserted-by":"publisher","unstructured":"Li Q, Chen N, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006866.pub3\n                    \n                  .","DOI":"10.1002\/14651858.CD006866.pub3"},{"key":"3395_CR41","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0277-9536(99)00047-7","volume":"48","author":"CE Schwartz","year":"1999","unstructured":"Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48:1531\u201348.","journal-title":"Soc Sci Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3395-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3395-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3395-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T19:15:26Z","timestamp":1570043726000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3395-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3395"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3395-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"4 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was reviewed and approved by the ethics committees of the study areas (i.e. Landes\u00e4rztekammer Hessen, Ethik-Kommission der \u00c4rztekammer Nordrhein, and Ethik-Kommission der Medizinischen Fakult\u00e4t der Universit\u00e4t M\u00fcnster) and all enrolled patients gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RSO, DC and AA are employees of the GSK group of companies. DC and AA own stock options of the GSK group of companies. SM is a freelance consultant working on behalf of GSK Vaccines (Wavre, Belgium). JS has nothing to disclose. US received a grant from the GSK group of companies (as payment for advisory-board meeting) outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"496"}}